FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact.
Marianne VogsenJeanette Dupont JensenIvar Yannick ChristensenOke GerkeAnne Marie Bak JyllingLisbet Brønsro LarsenPoul-Erik BraadKatrine Lydolph SøeCamilla BilleMarianne EwertzMalene Grubbe HildebrandtPublished in: Breast cancer research and treatment (2020)
FDG-PET/CT had a substantial impact on staging and change of treatment in women with high-risk primary breast cancer, and further examination of incidental findings was considered clinically relevant. Our findings suggest that FDG-PET/CT should be considered for primary staging in high-risk primary breast cancer to improve treatment planning.
Keyphrases